BSE: GLAXO - GlaxoSmithKline Pharmaceuticals Limited

Yield per half year: +5.23%
Dividend yield: +1.80%

Compare companies

Download the report:

Excel

Word

PDF

	GlaxoSmithKline Pharmaceuticals Limited	Cipla Limited	Biocon Limited
Capitalization
Price	2820.3999	1475.5	348.3
Price priv.
Number of shares, million	169.41	807.37	1196.8
Capitalization, billion	235.86	846.5	299.31
EBITDA, billion	9.04	53.2	24.29
EV, billion	218.09	820.34	446.74
Profit and loss report
Net profit, billion	5.9	41.22	10.23
Revenue, billion	34.42	254.47	141.96
EPS	34.83	51.05	8.54
Balance
Assets, billion	35.57	327.18	560.71
Debt, billion	0.1554	3.85	157.3
Balance cost, billion	17.78	267.06	197.84
Cash, billion	0.6417	6.4	12.33
Coefficients
Dividend yield, %	1.8	0.5498	0.4195
Dividend	44	13	0.5
Dividend yield priv., %	0	0	0
Dividend priv.	0	0	0
Dividends/profit, %	91.8	16.65	19.85
P/S	9.66	4.7	2.13
P/BV	18.71	4.46	1.19
P/E	56.38	29.01	29.51
Ev/Ebitda	24.13	17.88	16.97
Debt/Ebitda	0.0172	0.0724	6.48
Efficiency
ROE	33.53	16.45	5.43
ROA	17.14	13.26	1.89
ROIC	0	14.66	1.86
Ebitda margin	26.26	20.91	17.11
Net margin	17.14	16.2	7.2
Momentum
1 week, price changes	-0.8442 %	-3.01 %	+0.4839 %
1 month, price changes	+10.86 %	+0.2939 %	+6.71 %
3 months, price changes	+26.53 %	-1.45 %	-1.1 %
6 months, price changes	+5.23 %	-12.21 %	-7.07 %
1 year, price changes	+50.75 %	+0.0921 %	+33.53 %
3 years, price changes	+83.59 %	+42.61 %	+0.1022 %
5 years, price changes	+111.06 %	+230.86 %	+11.69 %
10 years, price changes

More data >>

More functionality and data for company and portfolio analysis is available by subscription